Tether, well-known for its stablecoin in the cryptocurrency market, has recently made a significant shift in its focus by investing $200 million in Blackrock Neurotech, a company specializing in medical devices. This strategic investment marks a new direction for Tether as it ventures into the realm of healthcare technology. The decision to invest in Blackrock Neurotech highlights Tether's commitment to diversifying its portfolio and exploring opportunities beyond the crypto space.
The investment was made through Tether's venture division, Tether Evo, which focuses on supporting innovative startups and companies with high growth potential. By injecting $200 million into Blackrock Neurotech, Tether Evo aims to assist the company in commercializing its cutting-edge medical devices. This financial backing will enable Blackrock Neurotech to further develop and bring its products to market, ultimately contributing to advancements in healthcare technology and improving patient care.
Dogecoin Expected To Surge Amid Market Rally, Analysts Predict Significant Gains
Dogecoin (DOGE) surged significantly this week, breaking key resistance levels and prompting bullish predictions from analysts due to positive technic
ICP Releases Updated Roadmap Focused On Decentralized AI And Interoperability, Prices Drop 10%
The DFINITY Foundation's new roadmap for Internet Computer Protocol (ICP) focuses on integrating decentralized AI, enhancing on-chain privacy, and imp
Solana's Pump.fun Platform Faces Major Exploit, $80 Million Stolen
Pump.fun, a Solana-based platform for meme coins, was exploited through flash loans, resulting in the theft of nearly 2,000 SOL.
Solana Soars Over 12% Amid Staking Launch, Bullish Metrics, And New Records
Solana's token (SOL) surged about 13%, reaching $162, driven by Robinhood's new staking service in Europe and cooling US inflation.
French Regulator AMF Warns Against Bybit Crypto Exchange
The AMF, France's securities regulator, has issued a renewed warning against cryptocurrency exchange Bybit, blocked user access to its website, and ur